While progress has been made in reducing the number of youth smokers, the rate of decline has slowed. Every day, about 3,800 adolescents (ages 11 to 17) smoke a cigarette for the first time. According to the American Lung Association, if the U.S. tobacco use patterns persist, more than 6 million children are estimated to die prematurely from smoking-related disease. This program will educate clinicians about evidence-based methods for reducing tobacco use in adolescents.
The goal of this continuing education program is to educate nurses, health educators, physicians, respiratory therapists and social workers about how to reduce tobacco use in adolescents. After studying the information presented here, you will be able to:
- Describe the health impact of smoking
- Identify factors that influence adolescents to smoke
- Indicate strategies to prevent and eliminate teenage smoking
This CE course is approved for respiratory therapists.
This program has been approved for 1 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving, TX 75063. AARC Sponsor Id. 9514012. This is a nontraditional course. The course has been approved from 7/15/2009 to 1/1/2014 and 2/15/2014 to 2/15/2016.
If you are a respiratory therapist, remember to give us your AARC member number when filling out your license number information.
Gannett Education is also approved by the Florida Board of Respiratory Care (provider #FBN 50-1489).
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no real or perceived conflicts of interest that relate to this educational activity. Gannett Education guarantees this educational activity is free from bias. There is no commercial or in-kind support provided for this online educational activity.
Please see CE Course Instructions to learn how to earn CE credit for this module. For successful completion of this course, learners must read the course, and complete a posttest and evaluation survey.
This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which is approved by the Food and Drug Administration (FDA).
The approval status for this educational activity, granted by the AARC, does not expressly or implicitly confer AARC endorsement of the activity’s content.
This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.